Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease
- PMID: 19543899
- DOI: 10.1007/s00384-009-0748-5
Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease
Abstract
Background and aims: Patients with ulcerative colitis (UC) and Crohn's disease (CD) have a high risk for colorectal cancer (CRC). To understand the molecular basis of colitis-associated CRC, we analyzed alterations in TP53, APC, K-ras, and DCC genes in the non-dysplastic UC and CD colon.
Materials and methods: Endoscopic biopsies were collected from six predefined colon sites of 35 UC and 12 CD patients for DNA extraction and genetic analysis.
Results: A mutation was found in codon 1141 of the APC gene of two CD patients, being somatic in one and germinative in the other. The mutation seen in both patients was a base exchange of thymine for cytosine, resulting in an exchange of leucine for serine. We did not detect any mutations in the other samples analyzed.
Conclusions: Mutations in APC gene may occur in the non-dysplastic CD mucosa of patients with disease for more than 10 years. The follow-up of these patients will show the likelihood of mutant APC progressing to CRC in CD. Further analysis will be required for evaluating the impact of these findings in the context of cancer surveillance in inflammatory bowel disease.
Similar articles
-
Alterations in K-ras, APC and p53-multiple genetic pathway in colorectal cancer among Indians.Tumour Biol. 2013 Jun;34(3):1901-11. doi: 10.1007/s13277-013-0734-y. Epub 2013 Mar 24. Tumour Biol. 2013. PMID: 23526092
-
Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.Rev Gastroenterol Mex. 2014 Apr-Jun;79(2):79-89. doi: 10.1016/j.rgmx.2014.05.001. Epub 2014 May 24. Rev Gastroenterol Mex. 2014. PMID: 24861525 English, Spanish.
-
Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.Oncotarget. 2016 Mar 1;7(9):10322-31. doi: 10.18632/oncotarget.7188. Oncotarget. 2016. PMID: 26862732 Free PMC article.
-
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies.Ann Oncol. 2005 May;16 Suppl 4:iv44-49. doi: 10.1093/annonc/mdi907. Ann Oncol. 2005. PMID: 15923428 Review.
-
[Molecular Pathogenesis of Colorectal Cancer].Klin Onkol. 2016 Winter;29(6):419-427. doi: 10.14735/amko2016419. Klin Onkol. 2016. PMID: 27951718 Review. Czech.
Cited by
-
Biology of colorectal cancer.Ecancermedicalscience. 2015 Apr 9;9:520. doi: 10.3332/ecancer.2015.520. eCollection 2015. Ecancermedicalscience. 2015. PMID: 25932044 Free PMC article. Review.
-
Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step.Cancer Genomics Proteomics. 2017 Sep-Oct;14(5):341-348. doi: 10.21873/cgp.20044. Cancer Genomics Proteomics. 2017. PMID: 28871001 Free PMC article.
-
Epithelial markers of colorectal carcinogenesis in ulcerative colitis and primary sclerosing cholangitis.World J Gastroenterol. 2013;19(14):2234-41. doi: 10.3748/wjg.v19.i14.2234. World J Gastroenterol. 2013. PMID: 23599650 Free PMC article.
-
Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer.Oxid Med Cell Longev. 2016;2016:9875298. doi: 10.1155/2016/9875298. Epub 2015 Dec 28. Oxid Med Cell Longev. 2016. PMID: 26823956 Free PMC article. Review.
-
Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Med Sci (Basel). 2018 Apr 13;6(2):31. doi: 10.3390/medsci6020031. Med Sci (Basel). 2018. PMID: 29652830 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous